PMID: 8942827Dec 1, 1996Paper

Racial differences in survival from gynecologic cancer

Obstetrics and Gynecology
M A MorganS C Rubin

Abstract

To determine whether survival from gynecologic cancer is different between African-American and white patients at an inner-city hospital with both a large clinic and a private service. We studied 538 patients (89 African American, 449 white) diagnosed with cervical, uterine, or ovarian cancer at a single institution from January 1, 1989 through December 31, 1993. Information was obtained on age, stage, site of disease, histology, and type of health insurance (public or commercial). Insurance coverage was used as a proxy for socioeconomic status. Overall survival was estimated by the method of Kaplan and Meier and compared by the log-rank test. Cox proportional hazard modeling was used to evaluate the effects of multiple factors on survival. African-American patients were significantly older and were more likely to have cervical cancer and public insurance than white patients. Overall survival was worse for African-American patients than for white patients (P < .05). However, stage for stage, there was no significant difference in survival between the groups. There was also no difference when patients were grouped by insurance status. African Americans had a significantly worse survival for cervical cancer than whites, and Afric...Continue Reading

Citations

Mar 8, 2005·Cancer Causes & Control : CCC·Sara J Newmann, Elizabeth O Garner
Mar 17, 2009·Cancer Causes & Control : CCC·Mishka TerplanSarah M Temkin
Jul 17, 2012·Digestive Diseases and Sciences·Raxitkumar JinjuvadiaSuthat Liangpunsakul
Feb 3, 2000·Journal of the American College of Surgeons·J I Sorosky
Jul 4, 1998·Cancer Practice·J J GuidryR J Winn
May 11, 1999·Obstetrical & Gynecological Survey·C S ChuJ E Wheeler
Nov 8, 2006·Journal of Women's Health·Katherine S EgglestonSusan R Tortolero
Oct 1, 2009·Journal of Women's Health·Ann L CokerMelanie Williams
Jan 13, 2016·International Journal of Cancer. Journal International Du Cancer·Candace SheppardEduardo L Franco
Sep 3, 2005·Gynecologic Oncology·Charles A LeathGroesbeck P Parham
Dec 26, 2012·Gynecologic Oncology·Ganna ChornokurCatherine M Phelan
Mar 14, 2003·American Journal of Obstetrics and Gynecology·John O SchorgeRobert L Coleman
Jan 29, 2002·Gynecologic Oncology·Steven W RobisonJohn H Farley
Feb 8, 2005·American Journal of Obstetrics and Gynecology·Annie YessaianWendy R Brewster
Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas C Randall, Katrina Armstrong
Jul 20, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kemi M DollAshlesha Patel
Jun 7, 2006·Epidemiology·Linda S CookNoel S Weiss
Jun 15, 2007·Cancer·John FarleyG Larry Maxwell
Mar 5, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Ann L CokerLois Ramondetta
May 8, 2020·Journal of Racial and Ethnic Health Disparities·Hamisu SalihuOmonike A Olaleye
Sep 24, 2004·Psycho-oncology·Kimlin T Ashing-GiwaM Belinda Tucker
Nov 7, 2021·Journal of Racial and Ethnic Health Disparities·Sanchita ChandraParamita Mandal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.